Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine.

about

LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening pow

P2860

Q52760538-3DFFBEFF-36C8-4CE9-8251-2F8E33442FFE

P2860

Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine.

Item

http://www.wikidata.org/entity/Q50673261

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Metabolic Profile Determinatio ...... thentic Human Blood and Urine.

@en

Metabolic Profile Determinatio ...... thentic Human Blood and Urine.

@nl

type

Item

label

Metabolic Profile Determinatio ...... thentic Human Blood and Urine.

@en

Metabolic Profile Determinatio ...... thentic Human Blood and Urine.

@nl

prefLabel

Metabolic Profile Determinatio ...... thentic Human Blood and Urine.

@en

Metabolic Profile Determinatio ...... thentic Human Blood and Urine.

@nl

P1476

Metabolic Profile Determinatio ...... thentic Human Blood and Urine.

@en

P2093

Amanda L A Mohr

http://www.w3.org/2001/XMLSchema#string

Barry K Logan

http://www.w3.org/2001/XMLSchema#string

Karen S Scott

http://www.w3.org/2001/XMLSchema#string

Keith-Dane H Temporal

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature

Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists

Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptors

A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug.

Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.

The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample.

An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons.

In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.

Identification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical Intoxication

2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.

P304

646-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAT/BKX029

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28472358

http://www.w3.org/2001/XMLSchema#string

Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine.

about

P2860

P2860

Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698